Part 3 of a 3-Part Series on 3-Parent Babies: Continuing my discussion on mitochondrial transfer, i.e., “three-parent babies,” there are two very interesting and under-appreciated issues to consider: How would U.S. approval of mitochondrial transfer impact parental rights and U.S. citizenship? While most of the current debate surrounding this treatment has revolved around ethical considerations, the laws regarding both parental… Read more →
A Patchwork of Regulation: Does the FDA have the Authority to Regulate Mitochondrial Transfer, i.e., “Three-Parent Babies”?
Part 2 of a 3-Part Series on 3-Parent Babies: I recently wrote why the US should follow Britain’s historic decision to approve mitochondrial transfer, i.e., “three-parent babies,” in order to assist women suffering from mitochondrial diseases. However, the approval process in the US would be very different from that in Britain, mainly due to the chaos surrounding regulation of assisted… Read more →
Why the US Should Follow Britain’s Historic Decision to Approve Mitochondrial Transfer, i.e., “Three-Parent Babies”
Part 1 of a 3-Part Series on 3-Parent Babies: In the summer of 2011 I took Professor June Carbone’s International Bioethics and Assisted Reproduction class where I first learned about an innovative in-vitro fertilization (IVF) technique known as mitochondrial transfer, or what is colloquially referred to as “three-parent babies” – much to the chagrin of many scientists. Since then, I… Read more →